Company Spotlight

Technological Advancements by Key Companies to Fuel the Global Cancer Screening Market

top cancer screening companies

Insights

DiaSorin S.p.A., Epigenomics AG, Techlab, Inc., Positive Biosciences Limited, MedGenome Labs Ltd, and 20/20 GeneSystems, among others are the key players in the global market of cancer screening.

As per the analysis by the Expert Market Research, the global cancer screening market is expected to grow in the forecast period of 2022-2027 at a CAGR of 9%, owing to surging cancer cases globally.

Cancer screening is crucial for identifying the disease before any symptoms develop. It has been projected that the industry will see tremendous growth in the forecast period owing to the increasing cases of cancer. New technologies like liquid biopsy are emerging at a high pace. Next Generation Sequence (NGS) is another technology that has been a focus of many companies as it allows simultaneous sequencing of targeted genomic areas in multiple samples to detect mutations. Such technological advancements are expected to aid the cancer screening market growth.

The expansion of the market is also being driven by the development of improved imaging to recognise the malignant tissues of various cancer types. The need for early detection and treatment of the chronic disease is growing because cancer is one of the main causes of mortality across the globe. Screenings are being utilised more frequently to find malignancies and lower the number of people who die from the disease.

The market is expanding as a result of the application of artificial intelligence (AI) to increase diagnosis speed and accuracy and reduce health disparities in settings with limited resources. Artificial intelligence is being employed in research by numerous organisations, including the National Cancer Institute, fuelling the market's expansion because it can help clinicians make better clinical decisions, detect particular gene mutations, and improve MRI guided biopsies.

When compared to the current standard of care for the early diagnosis of hepatocellular carcinoma (HCC) in patients with liver cirrhosis, Epigenomics' liver cancer panel performed much better, according to a news release issued by the company in April 2021. Patients with cirrhosis who also had early-stage, curable liver cancer were compared to those who only had cirrhosis. According to the study, the new Epigenomics Next Generation Sequencing (NGS) panel obtained a sensitivity of 68% at a specificity of 97% when paired with AFP (alpha-fetoprotein) testing in an ad hoc analysis.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top 6 Global Cancer Screening Companies:

DiaSorin S.p.A

Headquarters: Saluggia, Italy
Establishment: 2000
Website: https://www.diasorin.com/

Leading the market for laboratory diagnostics worldwide, DiaSorin focuses on immunodiagnostics and molecular diagnostics sectors. They have also been dealing with diagnostics to help patients and physicians make the best decisions during crucial moments. It is a multinational company operating across five continents with around 2,000 employees and more than 200 researchers. Their research and development centres are based in Italy, Germany, and the United States.

Epigenomics AG

Headquarters: Berlin, Germany
Establishment: 1998
Website: https://www.epigenomics.com/

The mission of Epigenomics AG is to transform cancer diagnosis through the deployment of novel DNA methylation biomarker technology. They create user-friendly blood-based diagnostic tests for a variety of cancer indications with a significant demand for healthcare. By employing blood for the liquid biopsy, they tend to help remove the most lethal cancers, such as liver, colorectal, and lung cancer, which can increase access to specific cancer screening. They are dedicated towards developing molecular diagnostics tests for cancer. The company’s research and development mission is to improve proprietary technology to maintain leadership in the DNA - methylation-based diagnostics for cancer testing. They use unique DNA methylation biomarkers to market blood-based cancer screening tests.

Techlab, Inc.

Headquarters: Virginia, United States
Establishment: 1989
Website: https://www.techlab.com/

Techlab develops, designs, and manufactures enteric diagnostics that are distributed worldwide. They are working in collaboration with universities and research around the world. They have received 25 patents along with several grant awards. The company's study encompasses markers of intestinal inflammation, the toxins produced by Clostridium difficile, amebiasis, and vaccine development. Its research focuses on enteric diseases and the microbiology of the digestive tract.

Positive Biosciences Limited

Headquarters: Maharashtra, India
Establishment: 1995
Website: https://positivebioscience.com/

The goal of the organisation is to bring the power of knowledge and technology to offer high quality cancer tests for cancer patients and their families. They provide DNA tests for cancer treatment and hereditary cancer screening. The company also uses the latest blood-based liquid biopsy technology to test patients.

MedGenome Labs limited

Headquarters: California, United States
Establishment: 2013
Website: http://www.medgenome.com/

MedGenome is a company that does research on medication discovery and diagnostics using genetics and clinical data. They are a market leader in India for genetic diagnostics. They additionally employ liquid biopsy tests, an NGS-based ctDNA test offered in India, to track the effectiveness of cancer treatment.

20/20 GeneSystems Inc.

Headquarters: Maryland, United States
Establishment: 2000
Website: https://2020gene.com/

The 20/20 GeneSystems Inc. company offers cutting-edge cancer diagnostic and bio-testing techniques that frequently satisfy unmet needs. Better tools are delivered by the company-powered cancer screening tests to improve early identification of the most prevalent cancers worldwide. Emergency responders frequently employ their emergency bio-detection firm, which features a unique BioCheck.

Also Read@ https://www.expertmarketresearch.com/pressrelease/global-cancer-screening-market

How to Purchase a Report

Website

To place an order through our website, select the license type mentioned on the report details page. Click on the ‘Buy Now’ button and fill in your details. Select your preferred mode of payment after which you will be redirected to the selected payment gateway. Follow the steps and proceed to checkout.

www.expertmarketresearch.com

Email

Enlisting all your requirements and queries along with details that include billing and delivery address and the preferred payment mode. Our customer service representative will revert to you within 24 hours.

[email protected]

Telephone

To place an order through telephone, call our sales team on the following numbers and our customer service representative will help you regarding the same.

+61 291 889 415

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124